The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors

Clinical and Translational Medicine
Chao HuHongping Xia

Abstract

Estrogen receptor (ER) is essential in reproductive development and is also the primary driver of breast cancers. Deregulation of ER may also be involved in tumorigenesis of other organs. To understand the role of ER in different tumor types, pan-cancer analysis of estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2) in various tumors and association with patients' survival were conducted using The Cancer Genome Atlas (TCGA) data. Gene methylation level was evaluated by the mean methylation level of CpG sites in the promoter region. The significant different DNA methylation between tumor and healthy tissues was shown in 10 tumor types for ESR1 and eight tumor types for ESR2. The methylation pattern was also varied across different TCGA tumors. The pan-cancer analysis showed significantly different mRNA expression of ESR1 in nine tumor types and ESR2 in four tumor types. Survival analysis showed that the effects of ERs expression on survival are diverse in different tumors. The expression of ERs was associated with tumor molecular subtypes and various clinical characteristics. ER correlated genes were mainly enriched in cancer and immune-related pathways. Our pan-cancer analysis data indicated that ERs might be signi...Continue Reading

References

Apr 10, 2007·Nature Genetics·Frederik HolstRonald Simon
Aug 17, 2011·Nature Reviews. Endocrinology·Eric R Prossnitz, Matthias Barton
Oct 12, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EjlertsenUNKNOWN Danish Breast Cancer Cooperative Group the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group
May 3, 2013·Nature·Cyriac KandothDouglas A Levine
Jul 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pascale FiselElke Schaeffeler
Nov 5, 2013·Nature Genetics·Weiyi ToySarat Chandarlapaty
Jun 24, 2014·Biochimica Et Biophysica Acta·Maria BondessonJan-Åke Gustafsson
Nov 25, 2014·Cell·UNKNOWN Cancer Genome Atlas Research Network
Jan 20, 2015·Molecular and Cellular Endocrinology·Muralidharan Anbalagan, Brian G Rowan
Nov 7, 2015·Cell·UNKNOWN Cancer Genome Atlas Research Network
Dec 29, 2015·Cancer Letters·Cecilia WilliamsJan-Åke Gustafsson
Aug 10, 2016·Cancer Cell·Siyuan ZhengRoel G W Verhaak
Nov 5, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karin ElebroHelena Jernström
Nov 12, 2016·Frontiers in Endocrinology·Monica MarzagalliPatrizia Limonta
Dec 18, 2016·Cancer Discovery·Weiyi ToySarat Chandarlapaty
Jun 18, 2017·Cell·UNKNOWN Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, UNKNOWN Cancer Genome Atlas Research Network
Aug 8, 2017·International Journal of Molecular Sciences·Li-Han HsuShu-Huei Kao
Aug 30, 2017·The Journal of Steroid Biochemistry and Molecular Biology·Joonwoo Park, YoungJoo Lee
Dec 30, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sophia MastorakiEvi Lianidou
Jan 24, 2018·Journal of the National Cancer Institute·Linda S LindströmUNKNOWN STO Trialists Group
Sep 18, 2018·Cancer Letters·Daoshan ZhengZhaoyu Li
Mar 19, 2019·Frontiers in Immunology·Mariana Segovia-Mendoza, Jorge Morales-Montor
May 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EjlertsenUNKNOWN Danish Breast Cancer Cooperative Group the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group

❮ Previous
Next ❯

Citations

Aug 4, 2021·Essays in Biochemistry·Erika L Garcia-Villatoro, Clinton D Allred

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE63514
GSE63678
GSE73360
GSE74602
GSE76297
GSE121248
GSE112790

Methods Mentioned

BETA
protein array
ESR

Software Mentioned

R
R clusterProfiler

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.